Chad Therapeutics (CHADQ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
| 12-2000 | 09-2000 | 06-2000 | 03-2000 | 12-1999 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -2,261 | -1,405 | -720 | -2,510 | -1,270 |
| Depreciation Amortization | 668 | 399 | 194 | 890 | 590 |
| Income taxes - deferred | N/A | N/A | N/A | 445 | 0 |
| Accounts receivable | -261 | -173 | 22 | 162 | 0 |
| Accounts payable and accrued liabilities | 87 | 148 | 152 | 87 | 0 |
| Other Working Capital | 1,290 | 1,151 | 608 | 3,350 | 2,510 |
| Other Operating Activity | 185 | 32 | -170 | -674 | 30 |
| Operating Cash Flow | $-292 | $152 | $86 | $1,750 | $1,860 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -125 | -100 | -79 | -120 | -70 |
| Investing Cash Flow | $-125 | $-100 | $-79 | $-120 | $-70 |
| Cash Flows From Financing Activities | |||||
| Financing Cash Flow | $N/A | $N/A | $N/A | $0 | $0 |
| Beginning Cash Position | 1,772 | 1,772 | 1,772 | 130 | 130 |
| End Cash Position | 1,355 | 1,824 | 1,779 | 1,770 | 1,930 |
| Net Cash Flow | $-417 | $52 | $7 | $1,630 | $1,790 |
| Free Cash Flow | |||||
| Operating Cash Flow | -292 | 152 | 86 | 1,750 | 1,860 |
| Capital Expenditure | -125 | -100 | -79 | -123 | 0 |
| Free Cash Flow | -417 | 52 | 7 | 1,627 | 1,860 |